IPO Price History
Closed
Corona Remedies Limited logo

Corona Remedies Limited IPO

Mainboard IPOListedCORONANSE
Current Market Price (CMP)
₹2,051.10(+93.14%)
Current Price (CMP)
₹2,051.10(+93.14%)

Live Market Quote

Listing Price & Gain
₹1(-99.91%)

Day 1 Exchange Open

IPO Issue Price
₹1,062

Band: ₹1008 - ₹1062

Total Subscription
137.04x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
08 Dec 2025
IPO Bidding Closes
10 Dec 2025
Allotment & Refunds
Completed
Exchange Listing Day
15 Dec 2025

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 137.04x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)278.52x
Non-Institutional Investors (NII / HNI)208.88x
Retail Individual Investors (RII)28.73x
Employees Reservation14.72x
Total Subscription137.04x
Updated as on 10-Dec-2025 19:00:00

Listing Day & Return Performance

Listing Day Gain-99.91%
₹1,062 (Issue) → ₹1 (List)
Per share profit: ₹-1061.00
Holding Return (Till Date)+93.14%
₹1,062 (Issue) → ₹2,051.10 (CMP)
Net gain per share: +₹989.10
Post-Listing Performance (Listing Day → Today):+205010.00%

About Corona Remedies Limited IPO

Corona Remedies Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 08 Dec 2025 and concluded on 10 Dec 2025, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹1008 - ₹1062.

During the bidding window, Corona Remedies Limited witnessed heavy demand with an overall subscription of 137.04 times. Institutional investors (QIB) subscribed 278.52x, non-institutional high-net-worth investors (NII) subscribed 208.88x, and retail individual investors (RII) bid 28.73x their reserved quota, alongside employee participation of 14.72x.

The equity shares of Corona Remedies Limited officially debuted on the stock exchanges on 15 Dec 2025 at an opening listing price of ₹1, delivering a listing day return of -99.91% (discount) over the final issue price. As per the latest market data, the stock trades at ₹2,051.10, representing an overall gain of +93.14% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Corona Remedies Limited IPO?
The issue price of Corona Remedies Limited IPO was fixed at ₹1,062 per equity share. The indicative bidding price band was ₹1008 - ₹1062.
What were the open, close, and listing dates for Corona Remedies Limited IPO?
Corona Remedies Limited IPO opened on 08 Dec 2025, closed on 10 Dec 2025, listed on 15 Dec 2025.
How much was Corona Remedies Limited IPO subscribed?
The IPO received an overall subscription of 137.04 times. Category-wise, QIBs subscribed 278.52x, NIIs subscribed 208.88x, and Retail investors subscribed 28.73x.
What was the listing price and listing gain of Corona Remedies Limited IPO?
Corona Remedies Limited IPO listed on the stock exchange at ₹1, delivering a listing discount of 99.91% compared to the IPO issue price of ₹1,062.
Is Corona Remedies Limited IPO a Mainboard or SME IPO?
Corona Remedies Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Corona Remedies Limited IPO since its IPO?
At the latest market quote of ₹2,051.10, Corona Remedies Limited IPO has generated an all-time return of +93.14% since its initial public offering.

Related Mainboard IPOs (2025)

GKSL
Gujarat Kidney and Super Speciality Limited
₹114-8.30%
KSHINTL
KSH International Limited
₹384-7.55%
ICICIAMC
ICICI Prudential Asset Management Company Limited
₹2,165-99.91%
NEPHROPLUS
Nephrocare Health Services Limited
₹460+2.45%